TB treatment is free or heavily subsidized for most people in the United States. State and local health departments operate TB control programs funded in part by the CDC, and these programs generally provide diagnosis, medication, and case management at no cost to the patient, regardless of insurance status, income, or immigration status. The specifics vary by state and county, but the public health system treats tuberculosis as a community safety issue, not just an individual medical problem, which is why cost is rarely allowed to become a barrier.
Why TB Is Treated as a Public Health Priority
Because active TB is contagious and can spread through the air, health departments have a strong incentive to find, treat, and cure every case. Leaving someone untreated doesn’t just harm that person. It puts entire communities at risk. This is why public health infrastructure exists to cover the cost of TB care even when a patient has no insurance, no income, or no documented immigration status. The goal is to ensure every person with TB completes their full course of treatment.
The CDC’s Division of Tuberculosis Elimination funds cooperative agreements with state and local health departments to support case finding, treatment completion, contact investigations, and testing for latent TB infection. These federal dollars flow to local programs that then provide care directly or connect patients to providers who can.
What Local Health Departments Typically Cover
Most county and city TB programs provide the following at no charge to the patient:
- TB testing: Skin tests or blood tests to detect infection. A blood-based screening test can cost between $32 and $190 at private labs, but health departments often offer testing for free or on a sliding scale.
- Chest X-rays and lab work: Imaging and sputum cultures needed to confirm active disease.
- Medications: The full course of antibiotics, which typically lasts six months for standard drug-susceptible TB.
- Directly Observed Therapy (DOT): A health worker watches you take each dose of medication, either in person or by video. This supervision is not billed to the patient. It exists to make sure treatment is completed, which protects both you and the public.
- Case management: Follow-up visits, lab monitoring, and coordination of care throughout treatment.
The actual cost of treating one person with drug-susceptible pulmonary TB in the U.S. is roughly $23,000 in direct healthcare expenses. That figure includes inpatient and outpatient care, diagnostics, and medications. Health departments absorb these costs through a mix of federal, state, and local funding.
Medicaid Coverage for TB
Federal law gives states the option to extend Medicaid eligibility specifically to low-income individuals infected with TB, even if they wouldn’t otherwise qualify for Medicaid. This option, created by Congress in 1993, covers outpatient TB-related services including prescribed drugs, physician visits, outpatient hospital services, lab and X-ray services, and clinic visits. States that elect this option can also cover targeted case management and directly observed therapy.
Not every state has adopted this optional coverage, so availability depends on where you live. But even in states that haven’t, local health departments typically fill the gap with their own TB programs. The practical result is that TB treatment is accessible without cost in most parts of the country, whether through Medicaid, a health department program, or both.
Access for Uninsured and Undocumented Residents
You do not need health insurance to receive TB treatment through a public health department. You also do not need to be a U.S. citizen or have a Social Security number. TB programs generally do not ask about immigration status because doing so would discourage people from seeking care, which would increase the risk of transmission. The public health rationale is straightforward: an untreated case of TB in any person is a threat to everyone around them.
If you have private insurance, your insurer may cover some or all of your TB care. But if you’re uninsured or underinsured, the health department program serves as the safety net. You can contact your local or state TB control program directly to find out what services are available in your area.
Latent TB vs. Active TB
Active TB disease, where a person is sick and potentially contagious, receives the most consistent free coverage across the country. Latent TB infection, where the bacteria are present but dormant and not causing symptoms, is a slightly different story. Many health departments do offer free testing and treatment for latent TB, but coverage is less uniform than it is for active disease.
Treating latent TB is dramatically cheaper. In California, preventing TB in one person through latent infection treatment costs about $857, compared to $43,900 to diagnose and treat one case of active TB disease. This cost difference is one reason public health officials push for more latent TB screening and treatment in high-risk populations. The U.S. Preventive Services Task Force recommends screening for latent TB in populations at elevated risk, and treatment is considered standard of care.
If you’ve been told you have latent TB, it’s worth calling your local health department to ask whether they provide free treatment. Many do, especially for people in high-risk groups or those without insurance.
Costs You Might Still Encounter
While the core TB treatment pathway through a health department is typically free, some expenses can still come up depending on your situation. If you’re diagnosed at a private clinic or emergency room before being connected to the health department, you may receive bills for that initial visit. Hospitalization for severe cases may generate charges that insurance or Medicaid would need to cover. And indirect costs like lost wages during treatment, transportation to clinic visits, and childcare are real burdens that most programs don’t address financially, though some offer incentives like transit vouchers or food assistance to help patients stay on track.
Video-based directly observed therapy has reduced one of these hidden costs significantly. When patients can take their medication on a video call instead of traveling to a clinic, their out-of-pocket time and travel expenses drop to nearly nothing. Studies comparing the two approaches found that patient costs for video DOT averaged about $1 per session, while in-person clinic DOT cost patients around $35 per session in time and transportation.